Lawrence Marshall Gold serves as Executive at 180 Life Sciences Corp., where they oversee executive responsibilities. Since joining the company, Lawrence Marshall Gold has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 4, 2023 involved receiving (via award) 21,455 shares valued at $0.
Lawrence Marshall Gold currently holds 24,745 shares of 180 Life Sciences Corp. (ATNF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence Marshall Gold has been a net neutral trader of ATNF stock. They have purchased $0 and sold $0 worth of shares.
Lawrence Marshall Gold's most recent insider trade was on Sep 4, 2023, when they sold 21,455 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 27, 2022 | ATNF | $0 | Award | 13,068 | $N/A | Discretionary |
| May 19, 2022 | ATNF | $14.4K | Award | 10,570 | $1.36 | Discretionary |
| Jan 14, 2022 | ATNF | $14.4K | Award | 4,728 | $3.04 | Discretionary |
| Aug 4, 2021 | ATNF | $35.0K | Award | 4,629 | $7.56 | Discretionary |
| Mar 4, 2021 | ATNF | $8.3K | Award | 2,101 | $3.94 | Discretionary |